| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.1B | $3.8B | $3.7B | $3.3B | $2.9B | $2.7B | $2.9B | $2.7B |
| Cost of Revenue | $2.2B | $2.1B | $2.1B | $1.9B | $1.7B | $1.5B | $1.6B | $1.6B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $1.0B | $0.9B | $0.9B | $0.7B | $0.7B | $0.6B | $0.7B | $0.6B |
| Operating Income | $0.9B | $0.8B | $0.7B | $0.6B | $0.5B | $0.4B | $0.6B | $0.5B |
| Net Income | $0.6B | $0.6B | $0.5B | $0.5B | $0.5B | $0.3B | $0.4B | $0.4B |
| EPS (Basic) | $7.48 | $6.85 | $6.15 | $5.20 | $5.37 | $3.41 | $4.29 | $4.58 |
| EPS (Diluted) | $7.44 | $6.82 | $6.12 | $5.19 | $5.34 | $3.39 | $4.26 | $4.54 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.2B | $4.5B | $4.3B | $4.0B | $3.1B | $3.1B | $3.0B | $2.8B |
| Current Assets | $1.4B | $1.4B | $1.4B | $1.2B | $1.1B | $1.1B | $1.0B | $0.9B |
| Cash & Equivalents | $0.4B | $0.5B | $0.5B | $0.3B | $0.4B | $0.5B | $0.4B | $0.3B |
| Total Liabilities | $3.2B | $3.0B | $3.0B | $3.0B | $2.3B | $2.2B | $2.2B | $2.2B |
| Current Liabilities | $0.8B | $0.7B | $1.1B | $0.7B | $0.6B | $0.5B | $0.5B | $0.5B |
| Stockholders' Equity | — | — | $1.3B | $0.9B | $0.8B | $0.8B | $0.8B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $0.7B | $0.6B | $0.5B | $0.5B | $0.5B | $0.5B | $0.5B |
| Investing Cash Flow | $-0.7B | $-0.2B | $-0.1B | $-1.0B | $-0.0B | $-0.1B | $-0.1B | $-0.4B |
| Capital Expenditures | — | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.1B | $0.0B |
| Financing Cash Flow | $-0.3B | $-0.4B | $-0.3B | $0.4B | $-0.5B | $-0.3B | $-0.3B | $-0.2B |